Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain.

Patassini S, Begley P, Xu J, Church SJ, Reid SJ, Kim EH, Curtis MA, Dragunow M, Waldvogel HJ, Snell RG, Unwin RD, Faull RL, Cooper GJ.

Biochim Biophys Acta. 2016 Sep;1862(9):1650-62. doi: 10.1016/j.bbadis.2016.06.002.

0

0

0

PUBMED

Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.

Wexler NS, Collett L, Wexler AR, Rawlins MD, Tabrizi SJ, Douglas I, Smeeth L, Evans SJ.

BMJ Open. 2016 Feb 23;6(2):e009070. doi: 10.1136/bmjopen-2015-009070. Review.

0

0

0

PUBMED

Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study.

Turner LM, Jakabek D, Wilkes FA, Croft RJ, Churchyard A, Walterfang M, Velakoulis D, Looi JC, Georgiou-Karistianis N, Apthorp D.

Brain Behav. 2016 Jul 27;6(12):e00511. doi: 10.1002/brb3.511.

0

0

0

PUBMED

Classification of Huntington's disease stage with support vector machines: A study on oculomotor performance.

Miranda Â, Lavrador R, Júlio F, Januário C, Castelo-Branco M, Caetano G.

Behav Res Methods. 2016 Dec;48(4):1667-1677.

0

0

0

PUBMED

An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington's disease related cardiomyopathy.

Toczek M, Zielonka D, Zukowska P, Marcinkowski JT, Slominska E, Isalan M, Smolenski RT, Mielcarek M.

Biochim Biophys Acta. 2016 Nov;1862(11):2147-2157. doi: 10.1016/j.bbadis.2016.08.019.

0

0

0

PUBMED

A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis.

Lupo F, Tibaldi E, Matte A, Sharma AK, Brunati AM, Alper SL, Zancanaro C, Benati D, Siciliano A, Bertoldi M, Zonta F, Storch A, Walker RH, Danek A, Bader B, Hermann A, De Franceschi L.

Blood. 2016 Dec 22;128(25):2976-2987. doi: 10.1182/blood-2016-07-727321.

0

0

0

PUBMED

The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease.

Rabinovich-Guilatt L, Siegler KE, Schultz A, Halabi A, Rembratt A, Spiegelstein O.

Br J Clin Pharmacol. 2016 Feb;81(2):246-55. doi: 10.1111/bcp.12792.

0

0

0

PUBMED

Altered Expression of the Long Noncoding RNA NEAT1 in Huntington's Disease.

Sunwoo JS, Lee ST, Im W, Lee M, Byun JI, Jung KH, Park KI, Jung KY, Lee SK, Chu K, Kim M.

Mol Neurobiol. 2016 May 25. [Epub ahead of print]

0

0

0

PUBMED

Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.

Kuljis DA, Gad L, Loh DH, MacDowell Kaswan Z, Hitchcock ON, Ghiani CA, Colwell CS.

PLoS One. 2016 Feb 12;11(2):e0147583. doi: 10.1371/journal.pone.0147583.

0

0

0

PUBMED

LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's Disease.

Chopra V, Quinti L, Khanna P, Paganetti P, Kuhn R, Young AB, Kazantsev AG, Hersch S.

J Huntingtons Dis. 2016 Dec 15;5(4):347-355.

0

0

0

PUBMED

Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.

Wilson H, Niccolini F, Haider S, Marques TR, Pagano G, Coello C, Natesan S, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M.

J Neurol Sci. 2016 Sep 15;368:243-8. doi: 10.1016/j.jns.2016.07.033.

0

0

0

PUBMED

Destination and source memory in Huntington's disease.

El Haj M, Caillaud M, Verny C, Fasotti L, Allain P.

J Neuropsychol. 2016 Mar;10(1):77-89. doi: 10.1111/jnp.12057.

0

0

0

PUBMED

N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

Wright DJ, Gray LJ, Finkelstein DI, Crouch PJ, Pow D, Pang TY, Li S, Smith ZM, Francis PS, Renoir T, Hannan AJ.

Hum Mol Genet. 2016 Jul 15;25(14):2923-2933.

0

0

0

PUBMED

Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes.

Guiretti D, Sempere A, Lopez-Atalaya JP, Ferrer-Montiel A, Barco A, Valor LM.

Neurobiol Dis. 2016 May;89:190-201. doi: 10.1016/j.nbd.2016.02.004.

0

0

0

PUBMED

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).

Carlozzi NE, Schilling SG, Lai JS, Paulsen JS, Hahn EA, Perlmutter JS, Ross CA, Downing NR, Kratz AL, McCormack MK, Nance MA, Quaid KA, Stout JC, Gershon RC, Ready RE, Miner JA, Barton SK, Perlman SL,

Qual Life Res. 2016 Oct;25(10):2441-55. doi: 10.1007/s11136-016-1386-3.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy